Composition:

Each 1 ml  solution contains Dexmedetomidine Hydrochloride 4.72 µg equivalent to 4 µg Dexmedetomidine per ml

Pharmaceutical Dosage Form:

Solution for I.V infusion

Indications:

ICU Sedation

For sedation of initially intubated patients during treatment in an intensive care setting. The use of MEDRELAXMIDINE by continuous infusion in these patients should not exceed 24 hours.

Procedural Sedation

For sedation of non-intubated patients prior to and/or during surgical and other procedures.

Dosage & Administration:

For dosing leaflet available upon request.

Package and Storage:

Carton box containing 50ml glass vial + inner leaflet.
Store at temperature not exceeding 30 °C and use immediately after opening without dilution.